Zhejiang Starry Pharmaceutical Co., Ltd. Class ASSE: 603520

Full Text of 2025 Semi-annual Report

Aug 29, 2025 · Issued by Zhejiang Starry Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Full Text of 2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment